期刊
ONCOLOGY LETTERS
卷 1, 期 2, 页码 253-259出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ol_00000045
关键词
vascular endothelial growth factor A; vascular endothelial growth factor receptor 1; vascular endothelial growth factor receptor-2; bevacizumab; FOLFOX; colorectal cancer
类别
资金
- [21591734]
For individualized bevacizumab-based therapy, non-invasive biomarkers are necessary This study assessed the predictive value of plasma vascular endothelial growth factor (VEGF)-A, soluble VEGF receptor (sVEGFR)-1 and sVEGFR-2 levels as biomarkers for clinical response and survival in advanced colorectal cancer (CRC) patients treated with bevacizumab and modified FOLFOX6 (mFOLFOX6) Forty-six unresectable advanced CRC patients and 20 healthy controls Were included in this study CRC patients were treated with bevacizumab and mFOLFOX6 Pretreatment plasma VEGF-A, sVEGFR-1 and sVEGFR-2 levels were measured using the multiplex immunoassay Plasma VEGF-A, sVEGFR-1 and sVEGFR-2 levels were significantly higher in CRC patients than in the healthy subjects The plasma sVEGFR-1 levels in the responder patients [complete response (CR)/partial response (PR)] and stable disease (SD) patients were significantly lower than those in the progressive disease (PD) patients (CR/PR vs PD, p=0 025, SD vs PD, p=0 032), while the plasma VEGF-A and sVEGFR-2 levels did not show any significant differences between the two groups of patients Patients with higher sVEGFR-1 levels showed a significantly poorer progression-free survival (PFS) and overall survival (OS) than those with lower VEGFR-1 levels In contrast, VEGF-A and sVEGFR-2 did not show any significant relationship between PFS and OS according to the status of each level In the multivariate Cox proportional hazard regression analysis, sVEGFR-1 levels showed a significant relationship between PFS and OS These results suggest that plasma sVEGFR-1 levels have a predictive value for clinical response and survival in advanced CRC patients treated with bevacizumab and mFOLFOX6 Larger scale studies are needed to further validate our results
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据